| Opportunity ID: |
329249 |
| Opportunity Number: |
CDC-RFA-IP21-2105 |
| Opportunity Title: |
Human Papillomavirus (HPV) Roundtable: Supporting a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.268
93.733 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
N/AThe award ceiling for this FOA is $450,000 per budget period. CDC will consider any applicationrequesting an award higher than this amount as nonresponsive and it will receive no further review. |
| Agency Code: |
HHS-CDC-NCIRD |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control – NCIRD |
| Posted Date: |
Oct 01, 2020 |
| Last Updated Date: |
Oct 01, 2020 |
| Estimated Synopsis Post Date: |
Feb 08, 2021 |
| Fiscal Year: |
2021 |
| Award Ceiling: |
$450,000 |
| Award Floor: |
$450,000 |
| Estimated Total Program Funding: |
$2,250,000 |
| Expected Number of Awards: |
1 |
| Description: |
The purpose of this cooperative agreement is to: (1). Advance a national network of cancer prevention organizations, immunization partners, and other stakeholders by creating and supporting a planning committee that prioritizes network activities, updates and disseminates educational resources, and expands the diversity of organizations represented within the network that positively impact HPV vaccination rates; (2). Convene a national meeting of network members to provide technical assistance and catalyze their support of efforts to increase HPV vaccine uptake; and (3). Create and support task groups to address priority areas identified by the national network, initiate high-priority pilot projects to reduce barriers to HPV vaccine uptake, and share lessons learned. By working toward these goals, the network can provide channels of education, outreach, and training structured for the public and healthcare providers. The network, through its engagement and coordination with stakeholders, will be equipped to increase public and provider understanding of the burden of HPV-associated cancers that can be prevented by HPV vaccination and to accelerate the full implementation of HPV vaccination to prevent HPV-associated cancers. |
| Version: |
1 |
|
